Bank of Montreal
AKCA

Bank of Montreal’s Akcea Therapeutics Inc AKCA Stock Holding History

Bank of Montreal’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,700
Closed -$26K – 5086
2019
Q3 		$26K Sell
1,700
-18,000
-91% -$383K ﹤0.01% 3950
2019
Q2 		$462K Hold
19,700
– – ﹤0.01% 2464
2019
Q1 		$558K Buy
+19,700
New +$574K ﹤0.01% 2247

Bank of Montreal's AKCA Position: Q4 2020 in Review

Bank of Montreal sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 6,510 shares — an estimated $118K sold.

Bank of Montreal first reported a position in AKCA in Q2 2018 and held it in 9 quarters. The position peaked at $558K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Bank of Montreal reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Bank of Montreal sold 6,510 Akcea Therapeutics Inc shares in Q4 2020, an estimated $118K.
  • Bank of Montreal first reported a position in Akcea Therapeutics Inc in Q2 2018 and held it in 9 quarters.
  • Bank of Montreal's Akcea Therapeutics Inc position peaked at $558K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.